Indeed, the emerging understanding of the mechanism of therapeutic failure of advanced prostate tumors involves upregulation of AR or activation of its transcriptional activity via a ligand-independent manner leading to castration-independent disease (43). This evidence concerns the gene AR and prostate neoplasm.